Novartis AG (NVS)
103.38
-0.48
(-0.46%)
USD |
NYSE |
Nov 14, 16:00
103.38
0.00 (0.00%)
After-Hours: 20:00
Novartis Total Return Level: 243.03 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 243.03 |
November 12, 2024 | 245.52 |
November 11, 2024 | 247.27 |
November 08, 2024 | 249.10 |
November 07, 2024 | 250.57 |
November 06, 2024 | 249.94 |
November 05, 2024 | 255.95 |
November 04, 2024 | 258.62 |
November 01, 2024 | 255.88 |
October 31, 2024 | 253.66 |
October 30, 2024 | 257.19 |
October 29, 2024 | 258.64 |
October 28, 2024 | 270.58 |
October 25, 2024 | 266.27 |
October 24, 2024 | 264.73 |
October 23, 2024 | 266.93 |
October 22, 2024 | 267.51 |
October 21, 2024 | 270.81 |
October 18, 2024 | 274.20 |
October 17, 2024 | 272.64 |
October 16, 2024 | 272.78 |
October 15, 2024 | 271.96 |
October 14, 2024 | 272.14 |
October 11, 2024 | 271.96 |
October 10, 2024 | 268.66 |
Date | Value |
---|---|
October 09, 2024 | 270.60 |
October 08, 2024 | 266.22 |
October 07, 2024 | 266.44 |
October 04, 2024 | 266.65 |
October 03, 2024 | 266.22 |
October 02, 2024 | 267.86 |
October 01, 2024 | 268.05 |
September 30, 2024 | 269.15 |
September 27, 2024 | 270.53 |
September 26, 2024 | 270.53 |
September 25, 2024 | 272.45 |
September 24, 2024 | 272.43 |
September 23, 2024 | 272.31 |
September 20, 2024 | 271.30 |
September 19, 2024 | 271.40 |
September 18, 2024 | 271.37 |
September 17, 2024 | 270.74 |
September 16, 2024 | 273.67 |
September 13, 2024 | 270.65 |
September 12, 2024 | 270.79 |
September 11, 2024 | 269.76 |
September 10, 2024 | 273.76 |
September 09, 2024 | 274.16 |
September 06, 2024 | 272.96 |
September 05, 2024 | 272.59 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
132.70
Minimum
Mar 23 2020
282.89
Maximum
Aug 30 2024
190.10
Average
175.38
Median
Jan 07 2021
Total Return Level Benchmarks
Amgen Inc | 425.02 |
AstraZeneca PLC | 394.72 |
Johnson & Johnson | 499.89 |
Eli Lilly and Co | 2343.87 |
Monte Rosa Therapeutics Inc | 8.625 |